Arotech Corp. (ARTX) Misses Q4 EPS by 3c

Arotech Corp. (NASDAQ: ARTX) reported Q4 EPS of $0.01, $0.03 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $21.5 million versus the consensus estimate of $27.04 million.

Fourth Quarter 2016 Financial Highlights:

• Total revenues of $21.5 million versus $27.4 million for the same time last year and $24.3 million from the prior quarter
• Net loss from continuing operations of $(2.0) million or $(0.08) per basic and diluted share versus net income from continuing operations of $0.7 million or $0.03 per basic and diluted share for the fourth quarter of 2015
• Adjusted EPS of $0.01 versus $0.07 for the same time last year and $0.10 from the prior quarter (reconciliation to diluted EPS appears in tables below)
• Adjusted EBITDA of $0.8 million compared to $2.6 million for the same time last year and $3.1 million from the prior quarter (reconciliation to diluted net income (loss) per share continuing operations appears in tables below)

For earnings history and earnings-related data on Arotech Corp. (ARTX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c